Cardiovascular, mortality, and kidney outcomes with GLP1-RAs in patients with T2D

Abstract

This systematic review and meta-analysis of cardiovascular outcome trials examines the effects of GLP-1RA in the treatment of patients with type 2 diabetes.

Topics: 

Citation
Kristensen SL et al. Lancet Diabetes Endocrinol 2019;7(10):776-785.